Business Description

Description
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.18
Equity-to-Asset -0.49
Debt-to-Equity -1.47
Debt-to-EBITDA -0.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -45.68
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 29.37
14-Day RSI 32.89
6-1 Month Momentum % -58.33
12-1 Month Momentum % -75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.2
Quick Ratio 0.76
Cash Ratio 0.18
Days Inventory 550.55
Days Sales Outstanding 71.38
Days Payable 181.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.1
Shareholder Yield % 448.17

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 54.9
Operating Margin % -267.26
Net Margin % -273.96
FCF Margin % -187.65
ROE % -857.32
ROA % -126.43
ROIC % -346.45
ROC (Joel Greenblatt) % -510.12
ROCE % -243.43
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.38
EV-to-EBIT -0.67
EV-to-EBITDA -0.68
EV-to-Revenue 1.79
EV-to-FCF -0.95
Earnings Yield (Greenblatt) % -149.25
FCF Yield % -271.39

Financials

BNKL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BNKL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bionik Laboratories Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.805
EPS (TTM) ($) -0.72
Beta -2.22
Volatility % 111.07
14-Day RSI 32.89
14-Day ATR ($) 0.00001
20-Day SMA ($) 0.1
12-1 Month Momentum % -75
52-Week Range ($) 0.031 - 1.45
Shares Outstanding (Mil) 12.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bionik Laboratories Corp Filings

Filing Date Document Date Form
No Filing Data

Bionik Laboratories Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Bionik Laboratories Corp Frequently Asked Questions

What is Bionik Laboratories Corp(BNKL)'s stock price today?
The current price of BNKL is $0.10. The 52 week high of BNKL is $1.45 and 52 week low is $0.03.
When is next earnings date of Bionik Laboratories Corp(BNKL)?
The next earnings date of Bionik Laboratories Corp(BNKL) is .
Does Bionik Laboratories Corp(BNKL) pay dividends? If so, how much?
Bionik Laboratories Corp(BNKL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1